Long-term presence of HBV in the sera of chronic hepatitis B patients with HBsAg seroclearance

Intervirology

Volumn 50, Issue 3, 2007, Pages 161-165

  Arase, Yasuji ^a   Suzuki, Fumitaka ^a   Suzuki, Yoshiyuki ^a   Saitoh, Satoshi ^a   Kobayashi, Masahiro ^a   Akuta, Norio ^a   Someya, Takashi ^a   Hosaka, Tetsuya ^a   Sezaki, Hitomi ^a   Sato, Junko ^a   Kobayashi, Mariko ^a   Ikeda, Kenji ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Chronic hepatitis B; Hepatitis B virus DNA; Seroclearance, hepatitis B surface antigen

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; INTERFERON; PREDNISOLONE;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; DRUG WITHDRAWAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DNA, VIRAL; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; REGRESSION ANALYSIS; RISK FACTORS; SERUM; VIRAL REGULATORY PROTEINS; VIREMIA;

HEPATITIS B VIRUS;

EID: 34247173078     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098958     Document Type: Article

References (21)

1. Liaw YF, Tai DI, Chu CM, Chen TJ: The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology 1988; 8: 493-496.
2. De Franchis R, Meucci G, Vecchi M, Tatarella M, Colombo M, Del Ninno E, Rumi MG, Donato MF, Ronchi G: The natural history of asymptomatic hepatitis B surface antigen carriers. Ann Intern Med 1993;118:191-194.
3. Viola LA, Barison IG, Coleman JC, Paradinas FJ, Fluker JL, Evans BA, Murray-Lyon IM: Natural history of liver disease in chronic hepatitis B surface antigen carriers. Lancet 1981;2:1156-1159.
4. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J: Effect of alphainterferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med 1993;119:312-323.
5. Niederau C, Heintges T, Lange S, Goldmann G, Niederau CM, Mohr L, Haussinger D: Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B. N Engl J Med 1996;334:1422-1427.
6. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, Liaw YF: Long- term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522-1527.
7. Lindsay KL, Redeker AG, Ashcavai M: Delayed HBsAg clearance in chronic hepatitis B viral infection. Hepatology 1981;1:586-589.
8. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC: Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B infection: a prospective study. Hepatology 1991;13:627-631.
9. Chen YC, Sheen IS, Chu CM, Liaw YF: Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B with or without concurrent infection. Gastroenterology 2002;123:1084-1089.
10. Arase Y, Ikeda K, Murashima N, Chayama K, Tsubota A, Koida I, Suzuki Y, Saitoh S, Kobayashi M, Kobayashi M, Kumada H: Time course of histological changes in patients with a sustained biochemical and virological response to corticosteroid withdrawal therapy for chronic hepatitis B. Am J Gastroenterol 1999;94:3304-3309.
11. Perrillo RP, Brunt EM: Hepatic histologic and immunochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen. Ann Intern Med 1991;115:113-115.
12. Chung HT, Lai CL, Lok ASF: Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995;22:25-29.
13. Blum HE, Liang TJ, Galun E, Wands JR: Persistence of hepatitis B viral DNA after serological recovery from hepatitis B virus infection. Hepatology 1991;14:56-63.
14. Yuen MF, Ho Wong DKH, Sahlon E, Tse E, Ng IO, Yuan HJ, Sin CW, Sander TJ, Boume EJ, Hall JG, Condreay LD, Lai CL: HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology 2004;39:1694-1701.
15. Ahn SH, Park YN, Park JY, Change HY, Lee JM, Shin JE, Han KH, Park C, Moor YM, Chon CY: Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol 2005;42:188-194.
16. Yotsuyanagi H, Yasuda K, Iino S, Moriya K, Shintani Y, Fujie H, Tsutsumi T, Kimura S, Koike K: Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 1998;27:1377-1382.
17. Huo TI, Wu JC, Lee PC, Chan GY, Lui WY, Tsay SH, Ting LT, Change FY, Lee SD: Seroclearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998;28:231-236.
18. Usuda S, Okamoto H, Iwanari H, Baba K, Usuda F, Miyakawa Y, Mayumi M: Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 1999;80:97-112.
19. Hoofnagle JH, Davis GL, Pappas SC, Hanson RG, Peters M, Avian MI, Waggoner JG, Jones FA, Seeff LB: A short course of prednisolone in chronic type B hepatitis. Ann Intern Med 1986;104:12-17.
20. Lau JY, Bird GL, Gimson AE, Alexander GJ, Williams R: Treatment of HBV reactivation after withdrawal of immunosuppression. Lancet 1991;337:802.
21. Nakamura Y, Motokura T, Fujita A, Yamashita T, Ogata E: Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Cancer 1996;78:2210-2215.